182 related articles for article (PubMed ID: 31556993)
1. Inhibiting
Zheng H; Williams JT; Aleiwi B; Ellsworth E; Abramovitch RB
ACS Chem Biol; 2020 Jan; 15(1):52-62. PubMed ID: 31556993
[No Abstract] [Full Text] [Related]
2. Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence.
Zheng H; Colvin CJ; Johnson BK; Kirchhoff PD; Wilson M; Jorgensen-Muga K; Larsen SD; Abramovitch RB
Nat Chem Biol; 2017 Feb; 13(2):218-225. PubMed ID: 27992879
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting DosRST as a new approach to tuberculosis therapy.
Zheng H; Abramovitch RB
Future Med Chem; 2020 Mar; 12(5):457-467. PubMed ID: 32053005
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis DosS binds H
Sevalkar RR; Glasgow JN; Pettinati M; Marti MA; Reddy VP; Basu S; Alipour E; Kim-Shapiro DB; Estrin DA; Lancaster JR; Steyn AJC
Redox Biol; 2022 Jun; 52():102316. PubMed ID: 35489241
[TBL] [Abstract][Full Text] [Related]
5. The Mycobacterium DosR regulon structure and diversity revealed by comparative genomic analysis.
Chen T; He L; Deng W; Xie J
J Cell Biochem; 2013 Jan; 114(1):1-6. PubMed ID: 22833514
[TBL] [Abstract][Full Text] [Related]
6. DevS/DosS sensor is bifunctional and its phosphatase activity precludes aerobic DevR/DosR regulon expression in Mycobacterium tuberculosis.
Kaur K; Kumari P; Sharma S; Sehgal S; Tyagi JS
FEBS J; 2016 Aug; 283(15):2949-62. PubMed ID: 27327040
[TBL] [Abstract][Full Text] [Related]
7.
Simcox BS; Tomlinson BR; Shaw LN; Rohde KH
Front Cell Infect Microbiol; 2023; 13():1144210. PubMed ID: 36968107
[No Abstract] [Full Text] [Related]
8. Oxygen triggers signal transduction in the DevS (DosS) sensor of Mycobacterium tuberculosis by modulating the quaternary structure.
Lobão JBDS; Gondim ACS; Guimarães WG; Gilles-Gonzalez MA; Lopes LGF; Sousa EHS
FEBS J; 2019 Feb; 286(3):479-494. PubMed ID: 30570222
[TBL] [Abstract][Full Text] [Related]
9. Convergence of Ser/Thr and two-component signaling to coordinate expression of the dormancy regulon in Mycobacterium tuberculosis.
Chao JD; Papavinasasundaram KG; Zheng X; Chávez-Steenbock A; Wang X; Lee GQ; Av-Gay Y
J Biol Chem; 2010 Sep; 285(38):29239-46. PubMed ID: 20630871
[TBL] [Abstract][Full Text] [Related]
10. Insights on how the Mycobacterium tuberculosis heme uptake pathway can be used as a drug target.
Owens CP; Chim N; Goulding CW
Future Med Chem; 2013 Aug; 5(12):1391-403. PubMed ID: 23919550
[TBL] [Abstract][Full Text] [Related]
11. MprA and DosR coregulate a Mycobacterium tuberculosis virulence operon encoding Rv1813c and Rv1812c.
Bretl DJ; He H; Demetriadou C; White MJ; Penoske RM; Salzman NH; Zahrt TC
Infect Immun; 2012 Sep; 80(9):3018-33. PubMed ID: 22689819
[TBL] [Abstract][Full Text] [Related]
12. NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G.
Kidwai S; Bouzeyen R; Chakraborti S; Khare N; Das S; Priya Gosain T; Behura A; Meena CL; Dhiman R; Essafi M; Bajaj A; Saini DK; Srinivasan N; Mahajan D; Singh R
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285226
[TBL] [Abstract][Full Text] [Related]
13. A Bayesian Change point model for differential gene expression patterns of the DosR regulon of Mycobacterium tuberculosis.
Zhang Y; Hatch KA; Wernisch L; Bacon J
BMC Genomics; 2008 Feb; 9():87. PubMed ID: 18294384
[TBL] [Abstract][Full Text] [Related]
14. DosS Is required for the complete virulence of mycobacterium tuberculosis in mice with classical granulomatous lesions.
Gautam US; McGillivray A; Mehra S; Didier PJ; Midkiff CC; Kissee RS; Golden NA; Alvarez X; Niu T; Rengarajan J; Sherman DR; Kaushal D
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):708-16. PubMed ID: 25322074
[TBL] [Abstract][Full Text] [Related]
15. Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon.
Kumar A; Deshane JS; Crossman DK; Bolisetty S; Yan BS; Kramnik I; Agarwal A; Steyn AJ
J Biol Chem; 2008 Jun; 283(26):18032-9. PubMed ID: 18400743
[TBL] [Abstract][Full Text] [Related]
16. Targeting Mycobacterium tuberculosis nucleoid-associated protein HU with structure-based inhibitors.
Bhowmick T; Ghosh S; Dixit K; Ganesan V; Ramagopal UA; Dey D; Sarma SP; Ramakumar S; Nagaraja V
Nat Commun; 2014 Jun; 5():4124. PubMed ID: 24916461
[TBL] [Abstract][Full Text] [Related]
17. A chemical proteomics approach to profiling the ATP-binding proteome of Mycobacterium tuberculosis.
Wolfe LM; Veeraraghavan U; Idicula-Thomas S; Schürer S; Wennerberg K; Reynolds R; Besra GS; Dobos KM
Mol Cell Proteomics; 2013 Jun; 12(6):1644-60. PubMed ID: 23462205
[TBL] [Abstract][Full Text] [Related]
18. DevR (DosR) mimetic peptides impair transcriptional regulation and survival of Mycobacterium tuberculosis under hypoxia by inhibiting the autokinase activity of DevS sensor kinase.
Kaur K; Taneja NK; Dhingra S; Tyagi JS
BMC Microbiol; 2014 Jul; 14():195. PubMed ID: 25048654
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium tuberculosis growth following aerobic expression of the DosR regulon.
Minch K; Rustad T; Sherman DR
PLoS One; 2012; 7(4):e35935. PubMed ID: 22558276
[TBL] [Abstract][Full Text] [Related]
20. Cmr is a redox-responsive regulator of DosR that contributes to M. tuberculosis virulence.
Smith LJ; Bochkareva A; Rolfe MD; Hunt DM; Kahramanoglou C; Braun Y; Rodgers A; Blockley A; Coade S; Lougheed KEA; Hafneh NA; Glenn SM; Crack JC; Le Brun NE; Saldanha JW; Makarov V; Nobeli I; Arnvig K; Mukamolova GV; Buxton RS; Green J
Nucleic Acids Res; 2017 Jun; 45(11):6600-6612. PubMed ID: 28482027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
